FDA Adverse Event Injury Summary report: N

COREVALVE 29MM AORTIC VALVE

MDR report key: 3950029 · Received July 22, 2014

Report

Report Number
2025587-2014-00503
Event Type
Injury
Date Received
July 22, 2014
Date of Event
May 8, 2014
Report Date
August 18, 2014
Manufacturer
MEDTRONIC HEART VALVES DIVISION
Product Code
NPT
PMA / PMN Number
P130021
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
NY, US
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

CONDUCTION DISTURBANCES ARE KNOWN POTENTIAL ADVERSE EFFECTS ASSOCIATED WITH ANY CARDIAC OR THORACIC PROCEDURE (OPEN OR CATHETER-BASED) AND CAN BE RESOLVED WITH MEDICAL TREATMENT OR THE IMPLANT OF A PERMANENT PACEMAKER (WITH THE RISK-BENEFIT RATIO IN FAVOR OF IMPLANT OF THE PERCUTANEOUS AORTIC VALVE). A CONDUCTION DISTURBANCE DOES NOT INDICATE A DEVICE MALFUNCTION OR POTENTIAL MANUFACTURING ISSUE.

Additional Manufacturer Narrative · 1

THE PRODUCT REMAINS IMPLANTED AND THEREFORE HAS NOT BEEN RETURNED TO MEDTRONIC. ADDITIONAL INFORMATION HAS BEEN REQUESTED. A SUPPLEMENTAL REPORT WILL BE FILED WHEN THE INVESTIGATION IS COMPLETED OR IF ADDITIONAL INFORMATION IS RECEIVED. (B)(4).

Additional Manufacturer Narrative · 1

ONSET DATE OF THE HEART BLOCK WAS (B)(6) 2014, THE SAME DATE AS THE VALVE IMPLANT. THE PERMANENT PACEMAKER WAS IMPLANTED 1 DAY POST-VALVE IMPLANT ((B)(6) 2014).

Additional Manufacturer Narrative · 1

IF INFORMATION IS PROVIDED IN THE FUTURE, A SUPPLEMENTAL REPORT WILL BE ISSUED.

Description of Event or Problem · 1

MEDTRONIC RECEIVED INFORMATION THAT AN UNREPORTED TIME FOLLOWING THE IMPLANT OF THIS TRANSCATHETER BIOPROSTHETIC VALVE, THE PATIENT DEVELOPED COMPLETE HEART BLOCK. SUBSEQUENTLY A PERMANENT PACEMAKER WAS IMPLANTED. NO ADVERSE PATIENT EFFECTS OR OTHER DETAILS WERE REPORTED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
428830 COREVALVE 29MM AORTIC VALVE AORTIC VALVE, PROSTHESIS, PERCUTANEOUSLY DELIVERED NPT MEDTRONIC HEART VALVES DIVISION MCS-P3-29-AOA

Patients

Seq Age Sex Outcome Treatment
1 00089 YR Required Intervention